ConductScience.org, home

Paper26213619

Personalized management of hepatocellular carcinoma based on molecular information: future prospects.

Goossens N and 1 other. Clin Liver Dis (Hoboken), 2015. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Personalized management of hepatocellular carcinoma based on molecular information: future prospects. Papers, record 26213619. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26213619

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Personalized management of hepatocellular carcinoma based on molecular information: future prospects.
PubMed
Journal
Clin Liver Dis (Hoboken)
PubMed
Year
2015
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.12
iCite
Revised in PubMed
2020-09-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goossens NNicolas
2Hoshida YYujin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 DK099558NIDDK NIH HHSUnited StatesR01DK099558PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123268517Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.JAMA2012https://conductscience.org/library/papers/23268517PubMed
221374666Management of hepatocellular carcinoma: an update.Hepatology2011https://conductscience.org/library/papers/21374666PubMed
324462733A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.Gastroenterology2014https://conductscience.org/library/papers/24462733PubMed
419362088Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.Gastroenterology2009https://conductscience.org/library/papers/19362088PubMed
522873223Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.Curr Cancer Drug Targets2012https://conductscience.org/library/papers/22873223PubMed
618923165Gene expression in fixed tissues and outcome in hepatocellular carcinoma.N Engl J Med2008https://conductscience.org/library/papers/18923165PubMed
724122861Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma.Hepatology2014https://conductscience.org/library/papers/24122861PubMed
824084770Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy.Br J Cancer2013https://conductscience.org/library/papers/24084770PubMed
920194845Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.J Clin Oncol2010https://conductscience.org/library/papers/20194845PubMed
1018977053Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.J Hepatol2009https://conductscience.org/library/papers/18977053PubMed
1124557838Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.Science2014https://conductscience.org/library/papers/24557838PubMed
1225362482Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.Nat Genet2014https://conductscience.org/library/papers/25362482PubMed
1325635347A new initiative on precision medicine.N Engl J Med2015https://conductscience.org/library/papers/25635347PubMed
1423519950Genomic profiling of cell lines for personalized targeted therapy for hepatocellular carcinoma.Hepatology2013https://conductscience.org/library/papers/23519950PubMed
1523504622Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.Hepatology2013https://conductscience.org/library/papers/23504622PubMed
1622535689Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.Hepatology2012https://conductscience.org/library/papers/22535689PubMed
1724801353Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies.PLoS One2014https://conductscience.org/library/papers/24801353PubMed
1823589557Genomics-driven oncology: framework for an emerging paradigm.J Clin Oncol2013https://conductscience.org/library/papers/23589557PubMed
1925143343A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration.Gut2015https://conductscience.org/library/papers/25143343PubMed
2024375711Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.Hepatology2014https://conductscience.org/library/papers/24375711PubMed

See all 52 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
29524828Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus.Transl Oncol2018https://conductscience.org/library/papers/29524828PubMed
29376136Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.Hepatoma Res2018https://conductscience.org/library/papers/29376136PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
EPCAM4072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
GPC32719PubTator's text mininghttps://conductscience.org/library/genes/2719NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26213619

GET https://conductscience.org/api/papers/v1/26213619/references?page=2